Advanced Modalities
Regulatory, Tech Transfer & Support Services
Company Overview
About
Cellin Technologies is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Estonia
Founded:2014
Employees:2,387
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval ZM9047
FDA · #APR-3WI8XPSZ · 2020-12-01
Drug Approval LX1M91
FDA · #APR-O1IKSCVF · 2021-10-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-PVUF5YDD
Issued: 2020-01-11
Expires: 2025-10-04
Health Canada GMP
Health Canada
Cert #: CERT-KRDV0RA5
Issued: 2020-09-21
Expires: 2025-07-19
Loading CDMO intelligence...
Key facts about Cellin Technologies
- Cellin Technologies is headquartered in Estonia.
- Cellin Technologies was founded in 2014.
- Cellin Technologies has 2,387 employees.
- Cellin Technologies's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Cellin Technologies
Directory pages this company appears in, each with the full list of matching manufacturers.